150 related articles for article (PubMed ID: 10334633)
61. Erdosteine modulates radiocontrast-induced hepatotoxicity in rat.
Yesildağ A; Ozden A; Yilmaz HR; Uz E; Ağackiran Y; Yesildağ M; Yilmaz N; Sirmali R; Vural H; Naziroğlu M
Cell Biochem Funct; 2009 Apr; 27(3):142-7. PubMed ID: 19277994
[TBL] [Abstract][Full Text] [Related]
62. Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD.
Dal Negro RW; Visconti M; Micheletto C; Tognella S
Pulm Pharmacol Ther; 2008; 21(2):304-8. PubMed ID: 17889580
[TBL] [Abstract][Full Text] [Related]
63. Effect of mucolytic and expectorant drugs on tracheobronchial clearance in chronic bronchitis.
Clarke SW; Thomson ML; Pavia D
Eur J Respir Dis Suppl; 1980; 110():179-91. PubMed ID: 6938381
[No Abstract] [Full Text] [Related]
64. Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats.
Yilmaz HR; Uz E; Gökalp O; Ozçelik N; Ciçek E; Ozer MK
Toxicol Ind Health; 2008 Sep; 24(8):519-24. PubMed ID: 19039079
[TBL] [Abstract][Full Text] [Related]
65. Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway.
Ge LT; Liu YN; Lin XX; Shen HJ; Jia YL; Dong XW; Sun Y; Xie QM
Int Immunopharmacol; 2016 Apr; 33():90-8. PubMed ID: 26881857
[TBL] [Abstract][Full Text] [Related]
66. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
67. Effects of erdosteine on bleomycin-induced lung fibrosis in rats.
Boyaci H; Maral H; Turan G; Başyiğit I; Dillioğlugil MO; Yildiz F; Tugay M; Pala A; Erçin C
Mol Cell Biochem; 2006 Jan; 281(1-2):129-37. PubMed ID: 16328965
[TBL] [Abstract][Full Text] [Related]
68. Use of mucolytics in COPD: A Delphi consensus study.
Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
[TBL] [Abstract][Full Text] [Related]
69. Protection of erdosteine on smoke-induced peripheral neutrophil dysfunction both in healthy and in bronchitic smokers.
Ciaccia A; Papi A; Tschirky B; Fregnan B
Fundam Clin Pharmacol; 1992; 6(8-9):375-82. PubMed ID: 1292969
[TBL] [Abstract][Full Text] [Related]
70. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol.
Pfeifer S; Zissel G; Kienast K; Müller-Quernheim J
Eur J Med Res; 1997 Mar; 2(3):129-32. PubMed ID: 9113503
[TBL] [Abstract][Full Text] [Related]
71. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
[TBL] [Abstract][Full Text] [Related]
72. The effects of erdosteine, N-acetylcysteine and vitamin E on nicotine-induced apoptosis of cardiac cells.
Demiralay R; Gürsan N; Erdem H
J Appl Toxicol; 2007; 27(3):247-54. PubMed ID: 17216608
[TBL] [Abstract][Full Text] [Related]
73. Erdosteine protection against cigarette smoking-induced functional antiprotease deficiency in human bronchiolo-alveolar structures.
Vagliasindi M; Fregnan GB
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):238-41. PubMed ID: 2786856
[TBL] [Abstract][Full Text] [Related]
74. Effects of erdosteine on cyclosporin-A-induced nephrotoxicity.
Tutanc M; Arica V; Yılmaz N; Nacar A; Zararsiz I; Basarslan F; Tutanc OD; Nacar E
Hum Exp Toxicol; 2012 Jun; 31(6):565-73. PubMed ID: 21813577
[TBL] [Abstract][Full Text] [Related]
75. Effects of erdosteine on smoking-induced lipid peroxidation in healthy smokers.
Basyigit I; Yildiz F; Cekmen M; Duman C; Bulut O
Drugs R D; 2005; 6(2):83-9. PubMed ID: 15777101
[TBL] [Abstract][Full Text] [Related]
76. Erdosteine protects rat testis tissue from hypoxic injury by reducing apoptotic cell death.
Guven A; Ickin M; Uzun O; Bakar C; Gulec Balbay E; Balbay O
Andrologia; 2014 Feb; 46(1):50-58. PubMed ID: 23157213
[TBL] [Abstract][Full Text] [Related]
77. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats.
Yildirim Z; Sogut S; Odaci E; Iraz M; Ozyurt H; Kotuk M; Akyol O
Pharmacol Res; 2003 Feb; 47(2):149-56. PubMed ID: 12543063
[TBL] [Abstract][Full Text] [Related]
78. The protective role of erdosteine on testicular tissue after testicular torsion and detorsion.
Koc A; Narci A; Duru M; Gergerlioglu HS; Akaydin Y; Sogut S
Mol Cell Biochem; 2005 Dec; 280(1-2):193-9. PubMed ID: 16311923
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
[TBL] [Abstract][Full Text] [Related]
80. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog.
Tomkiewicz RP; App EM; De Sanctis GT; Coffiner M; Maes P; Rubin BK; King M
Pulm Pharmacol; 1995 Dec; 8(6):259-65. PubMed ID: 8819180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
